This Advisory Notice is effective February 6, 2015 and supersedes CME Group Market Regulation Advisory Notice RA1409-5 from December 15, 2014. It is being reissued solely as a result of minor revisions to Rule 531 which clarify that the provisions of Section B.5. of the Rule apply exclusively to transactions executed via open outcry.
Click HERE to view full advisory.
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.